Bexion Pharmaceuticals Announces the Opening of Phase I Part 3 First-in-Human Trial Using BXQ-350 for the Treatment of Cancer Beth Kaiser2026-03-18T10:23:16-04:00February 22, 2019|
Bexion Pharmaceuticals, Inc. Announces Initiation of Phase 1b Clinical Trial of BXQ-350 in Patients with Advanced Solid Tumors nrthkentucky3fPCaGN8adm2026-03-18T10:53:49-04:00November 1, 2017|
